Concepedia

Marie-Eve Garcia

MG

Statistics

Publications

6

Citations

342

H-Index

6

Active since

2017

Affiliations

Institut Bergonié(Current)

Hôpital de la Timone

Assistance Publique Hôpitaux de Marseille

Institut Claudius Regaud

Hospices Civils de Lyon

Marie-Eve Garcia is an author at Institut Bergonié specializing in oncology, cancer therapeutics, and cancer research.

ORCID

Top concepts

Publications per year

2017–2023

6

Publications

6

Lenvatinib for the Treatment of Radioiodine-Refractory Thyroid Cancer in Real-Life Practice

A. Berdelou, Isabelle Borget, Yann Godbert et al. · Thyroid · 2017 · 121 citations

A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud et al. · Clinical Cancer Research · 2023 · 85 citations · Full text

Efficacy and safety of nivolumab in patients with non-small cell lung cancer: a retrospective study in clinical practice

Marc Montana, Marie-Eve Garcia, Nathalie Ausias et al. · Journal of Chemotherapy · 2018 · 41 citations

, , +17

Targetable gene fusions identified in radioactive iodine refractory advanced thyroid carcinoma

Karin van der Tuin, Marie-Eve Garcia, Willem E. Corver et al. · European Journal of Endocrinology · 2019 · 41 citations · Full text

MERAIODE: A Redifferentiation Phase II Trial With Trametinib and Dabrafenib Followed by Radioactive Iodine Administration for Metastatic Radioactive Iodine Refractory Differentiated Thyroid Cancer Patients With a BRAFV600E Mutation (NCT 03244956)

Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud et al. · Journal of the Endocrine Society · 2021 · 29 citations · Full text

, , +15

1–5 of 6